Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral: Vanier Canada Graduate Scholarships

University of Toronto

$150,000.00

Differential Effects of KCC2 Downregulation on Spinal Dorsal Horn Interneurons Result in Neuropathic Pain

EF 2017-18

Résumé
Neuropathic pain is a type of chronic pain state caused by damage to the nervous system. About 3 million Canadians suffer from such pathological condition that is associated with increased drug prescriptions and visits to health care providers. As a consequence, quality of life is significantly impaired because of poor sleep, anxiety, and depression that are frequent and severe in patients with neuropathic pain. An incomplete understanding of molecular mechanisms in neuropathic conditions makes it difficult to predict which patients will experience pain after injury and how certain patients respond to specific drugs. Thus, more effective personalized pain therapies are needed. The spinal cord is an important gateway for pain messages transmitted to the brain. Inhibitory neurons control the flow of pain messages from the spinal cord to the brain. Any disruption of that inhibition - often referred to as the "pain gate" - disrupts normal pain processing and results in neuropathic pain. Specifically, downregulation of a molecule known as KCC2 is necessary and sufficient to explain many forms of neuropathic pain. However, we still do not know what cell types in the spinal cord express KCC2 and, consequently, how they are affected by KCC2 downregulation. In the proposed study, I will use transgenic mice to determine which cell types in the spinal cord experience KCC2 downregulation and how their function is impacted. I will also explore how therapeutic strategies can reduce neuropathic pain by upregulating KCC2. By the end of this project, we will learn more about how changes in KCC2 function affect the flow of pain messages transmitted to the brain. Our improved understanding of the underlying mechanisms behind neuropathic pain will help us develop more effective and efficient strategies to alleviate neuropathic pain by mitigating the effects of KCC2 downregulation.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
377323
Name
Kamaleddin Ezabadi Seyed Mohammad Amin
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Differential Effects of KCC2 Downregulation on Spinal Dorsal Horn Interneurons Result in Neuropathic Pain
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Chloride Regulation; Neural Coding; Neuropathic Pain; Spiking Pattern; Spinal Cord; Synaptic Inhibition
Abstract
Neuropathic pain is a type of chronic pain state caused by damage to the nervous system. About 3 million Canadians suffer from such pathological condition that is associated with increased drug prescriptions and visits to health care providers. As a consequence, quality of life is significantly impaired because of poor sleep, anxiety, and depression that are frequent and severe in patients with neuropathic pain. An incomplete understanding of molecular mechanisms in neuropathic conditions makes it difficult to predict which patients will experience pain after injury and how certain patients respond to specific drugs. Thus, more effective personalized pain therapies are needed. The spinal cord is an important gateway for pain messages transmitted to the brain. Inhibitory neurons control the flow of pain messages from the spinal cord to the brain. Any disruption of that inhibition - often referred to as the "pain gate" - disrupts normal pain processing and results in neuropathic pain. Specifically, downregulation of a molecule known as KCC2 is necessary and sufficient to explain many forms of neuropathic pain. However, we still do not know what cell types in the spinal cord express KCC2 and, consequently, how they are affected by KCC2 downregulation. In the proposed study, I will use transgenic mice to determine which cell types in the spinal cord experience KCC2 downregulation and how their function is impacted. I will also explore how therapeutic strategies can reduce neuropathic pain by upregulating KCC2. By the end of this project, we will learn more about how changes in KCC2 function affect the flow of pain messages transmitted to the brain. Our improved understanding of the underlying mechanisms behind neuropathic pain will help us develop more effective and efficient strategies to alleviate neuropathic pain by mitigating the effects of KCC2 downregulation.
Competitiondate
201711
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Kamaleddin Ezabadi, Seyed Mohammad Amin
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~